← Human Trials & Peer-Reviewed Studies
Vitamin D supplementation reduces serum lipids of children with hypertriacylglycerolemia: A randomized, triple-masked, placebo-controlled crossover trial.
Plain-language guide to PMID 34116394 (2021): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 44 children.
Key Facts
- PMID
- 34116394
- Journal
- Nutrition (Burbank, Los Angeles County, Calif.)
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Alves AGP et al. (5 authors)
- DOI
- 10.1016/j.nut.2021.111296
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
This study aimed to evaluate the effect of cholecalciferol supplementation on the body composition and metabolic profile of children with hypertriacylglycerolemia.
Who Took Part
According to the abstract, 44 children were involved.
By PubMed's age tags, the people studied were young children and children, women only.
This is a randomized, triple-masked, placebo-controlled, crossover trial of 44 Brazilian children with hypertriacylglycerolemia, age 4 to 11 y.
The sample included eutrophic and overweight/obese children according to body mass index for age, with sufficient and insufficient vitamin D basal levels.
How the Study Was Run
The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Neither the children nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
In the crossover set-up each of the children took both Vitamin D, K2, Magnesium and Zinc and the comparison in turn, acting as their own control.
The intervention lasted 34 wk, with two periods of 12 wk each separated by a 10-wk washout.
What Was Measured
The subject headings attached to it are Cholecalciferol, Dietary Supplements, Pediatric Obesity, Vitamin D and Vitamin D Deficiency.
Author keywords: Children, Clinical trial, Lipoproteins and Triacylglycerols.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 44 children.
Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2021 (Nutrition (Burbank, Los Angeles County, Calif.)), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.